Literature DB >> 29718377

Automatic recognition of self-acknowledged limitations in clinical research literature.

Halil Kilicoglu1, Graciela Rosemblat1, Mario Malicki2,3, Gerben Ter Riet2.   

Abstract

Objective: To automatically recognize self-acknowledged limitations in clinical research publications to support efforts in improving research transparency.
Methods: To develop our recognition methods, we used a set of 8431 sentences from 1197 PubMed Central articles. A subset of these sentences was manually annotated for training/testing, and inter-annotator agreement was calculated. We cast the recognition problem as a binary classification task, in which we determine whether a given sentence from a publication discusses self-acknowledged limitations or not. We experimented with three methods: a rule-based approach based on document structure, supervised machine learning, and a semi-supervised method that uses self-training to expand the training set in order to improve classification performance. The machine learning algorithms used were logistic regression (LR) and support vector machines (SVM).
Results: Annotators had good agreement in labeling limitation sentences (Krippendorff's α = 0.781). Of the three methods used, the rule-based method yielded the best performance with 91.5% accuracy (95% CI [90.1-92.9]), while self-training with SVM led to a small improvement over fully supervised learning (89.9%, 95% CI [88.4-91.4] vs 89.6%, 95% CI [88.1-91.1]). Conclusions: The approach presented can be incorporated into the workflows of stakeholders focusing on research transparency to improve reporting of limitations in clinical studies.

Mesh:

Year:  2018        PMID: 29718377      PMCID: PMC6016608          DOI: 10.1093/jamia/ocy038

Source DB:  PubMed          Journal:  J Am Med Inform Assoc        ISSN: 1067-5027            Impact factor:   4.497


  19 in total

1.  Automatically classifying sentences in full-text biomedical articles into Introduction, Methods, Results and Discussion.

Authors:  Shashank Agarwal; Hong Yu
Journal:  Bioinformatics       Date:  2009-09-25       Impact factor: 6.937

2.  Identifying scientific artefacts in biomedical literature: the Evidence Based Medicine use case.

Authors:  Hamed Hassanzadeh; Tudor Groza; Jane Hunter
Journal:  J Biomed Inform       Date:  2014-02-14       Impact factor: 6.317

3.  The Unified Medical Language System.

Authors:  D A Lindberg; B L Humphreys; A T McCray
Journal:  Methods Inf Med       Date:  1993-08       Impact factor: 2.176

4.  CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials.

Authors:  Kenneth F Schulz; Douglas G Altman; David Moher
Journal:  BMJ       Date:  2010-03-23

5.  Automatic classification of sentences to support Evidence Based Medicine.

Authors:  Su Nam Kim; David Martinez; Lawrence Cavedon; Lars Yencken
Journal:  BMC Bioinformatics       Date:  2011-03-29       Impact factor: 3.169

6.  Extraction of data deposition statements from the literature: a method for automatically tracking research results.

Authors:  Aurélie Névéol; W John Wilbur; Zhiyong Lu
Journal:  Bioinformatics       Date:  2011-10-13       Impact factor: 6.937

7.  RobotReviewer: evaluation of a system for automatically assessing bias in clinical trials.

Authors:  Iain J Marshall; Joël Kuiper; Byron C Wallace
Journal:  J Am Med Inform Assoc       Date:  2015-06-22       Impact factor: 4.497

8.  Why most published research findings are false.

Authors:  John P A Ioannidis
Journal:  PLoS Med       Date:  2005-08-30       Impact factor: 11.613

9.  Bio-SCoRes: A Smorgasbord Architecture for Coreference Resolution in Biomedical Text.

Authors:  Halil Kilicoglu; Dina Demner-Fushman
Journal:  PLoS One       Date:  2016-03-02       Impact factor: 3.240

Review 10.  'Spin' in published biomedical literature: A methodological systematic review.

Authors:  Kellia Chiu; Quinn Grundy; Lisa Bero
Journal:  PLoS Biol       Date:  2017-09-11       Impact factor: 8.029

View more
  3 in total

1.  Is the future of peer review automated?

Authors:  Robert Schulz; Adrian Barnett; René Bernard; Nicholas J L Brown; Jennifer A Byrne; Peter Eckmann; Małgorzata A Gazda; Halil Kilicoglu; Eric M Prager; Maia Salholz-Hillel; Gerben Ter Riet; Timothy Vines; Colby J Vorland; Han Zhuang; Anita Bandrowski; Tracey L Weissgerber
Journal:  BMC Res Notes       Date:  2022-06-11

2.  Toward assessing clinical trial publications for reporting transparency.

Authors:  Halil Kilicoglu; Graciela Rosemblat; Linh Hoang; Sahil Wadhwa; Zeshan Peng; Mario Malički; Jodi Schneider; Gerben Ter Riet
Journal:  J Biomed Inform       Date:  2021-02-26       Impact factor: 6.317

3.  Impact of peer review on discussion of study limitations and strength of claims in randomized trial reports: a before and after study.

Authors:  Kerem Keserlioglu; Halil Kilicoglu; Gerben Ter Riet
Journal:  Res Integr Peer Rev       Date:  2019-09-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.